Aurobindo Expects Interim Phase II/III COVID-19 Vaccine Data By July

Biosimilars Development Progresses

 
• By Vibha Ravi
  
Ampule, vials, pharmaceutical factory
Aurobindo Creating Vaccine, API Manufacturing Capacity • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip